| BE0032-50MG
| InVivoMAb anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0050-1MG
| InVivoMAb anti-mouse IL-10R (CD210)
| 1 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0019-1-5MG
| InVivoMAb anti-human CD47
| 5 mg
| BioXCell
| in vitro CD47 neutralization, in vivo CD47 neutral
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0024-100MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 100 mg
| BioXCell
| in vivo CD80 blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0014-50MG
| InVivoMAb anti-human CD25 (IL-2R?)
| 50 mg
| BioXCell
| in vivo regulatory T cell depletion in humanized m
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0003-3-50MG
| InVivoMAb anti-mouse CD4
| 50 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0076-1MG
| InVivoMAb anti-mouse Thy1 (CD90)
| 1 mg
| BioXCell
| in vitro T cell depletion
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0042-50MG
| InVivoMAb anti-mouse IL-2
| 50 mg
| BioXCell
| in vivo IL-2 neutralization, in vitro IL-2 neutral
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0058-5MG
| InVivoMAb anti-mouse TNF?
| 5 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0004-2-5MG
| InVivoMAb anti-human CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0066-1MG
| InVivoMAb anti-mouse Thy1.2 (CD90.2)
| 1 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion, W
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0019-5MG
| InVivoMAb anti-mouse CD45RB
| 5 mg
| BioXCell
| in vivo anti-CD45RB_mediated tolerance induction,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0085-50MG
| InVivoMAb mouse IgG2a isotype control, unknown specificity
| 50 mg
| BioXCell
|
|
| Mouse
|
| Request Quotation
| Request
|
| BE0061-1MG
| InVivoMAb anti-mouse CD8?
| 1 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0005-100MG
| InVivoMAb anti-human LFA-1? (CD11a)
| 100 mg
| BioXCell
| in vitro LFA-1 neutralization
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0004-2-25MG
| InVivoMAb anti-human CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0075-5MG
| InVivoMAb anti-mouse Ly6G/Ly6C (Gr-1)
| 5 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0043-100MG
| InVivoMAb anti-mouse IL-2
| 100 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0077-1MG
| InVivoMAb anti-mouse MHC Class I (H-2)
| 1 mg
| BioXCell
| ex vivo blocking of MHC I-dependent interactions,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0026-5MG
| InVivoMAb anti-mouse CD103
| 5 mg
| BioXCell
| in vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0031-50MG
| InVivoMAb anti-mouse OX40 (CD134)
| 50 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0015-1-50MG
| InVivoMAb anti-mouse CD28
| 50 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo CD
|
| Syrian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0059-5MG
| InVivoMAb anti-mouse ICOS
| 5 mg
| BioXCell
| in vivo blocking of ICOS/ICOSL signaling, Flow cyt
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0001-1-1MG
| InVivoMAb anti-mouse CD3?
| 1 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0043-1-25MG
| InVivoMAb anti-mouse IL-2
| 25 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0026-25MG
| InVivoMAb anti-mouse CD103
| 25 mg
| BioXCell
| in vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0014-1MG
| InVivoMAb anti-human CD25 (IL-2R?)
| 1 mg
| BioXCell
| in vivo regulatory T cell depletion in humanized m
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0001-2-5MG
| InVivoMAb anti-human CD3
| 5 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo T
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0019-1MG
| InVivoMAb anti-mouse CD45RB
| 1 mg
| BioXCell
| in vivo anti-CD45RB_mediated tolerance induction,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0003-3-25MG
| InVivoMAb anti-mouse CD4
| 25 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0009-25MG
| InVivoMAb anti-mouse CD18
| 25 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0036-100MG
| InVivoMAb anti-mouse NK1.1
| 100 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Request Quotation
| Request
|
| BE0006-1MG
| InVivoMAb anti-mouse LFA-1? (CD11a)
| 1 mg
| BioXCell
| in vivo LFA-1 neutralization, Flow cytometry
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0005-5MG
| InVivoMAb anti-human LFA-1? (CD11a)
| 5 mg
| BioXCell
| in vitro LFA-1 neutralization
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0061-25MG
| InVivoMAb anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0033-1-50MG
| InVivoMAb anti-mouse OX40L (CD134L)
| 50 mg
| BioXCell
| in vivo blocking of OX40/OX40L signaling, in vitro
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0026-1MG
| InVivoMAb anti-mouse CD103
| 1 mg
| BioXCell
| in vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0016-2-25MG
| InVivoMAb anti-mouse CD40
| 25 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0057-50MG
| InVivoMAb anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 50 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| Goat, Dog, Hamster, Human, Monkey, Mouse, Rat
| Request Quotation
| Request
|
| BE0071-50MG
| InVivoMAb anti-mouse/human VLA-4 (CD49d)
| 50 mg
| BioXCell
| in vivo VLA-4 neutralization, in vitro VLA-4 neutr
|
| Rat
| Human, Mouse
| Request Quotation
| Request
|
| BE0023-5MG
| InVivoMAb anti-human CD71
| 5 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Mouse
| Human
| Request Quotation
| Request
|
| BE0031-25MG
| InVivoMAb anti-mouse OX40 (CD134)
| 25 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation,
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0001-1FAB-10MG
| InVivoMAb anti-mouse CD3? F(ab')2 fragment
| 10 mg
| BioXCell
| in vivo T cell depletion
|
| Armenian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0076-5MG
| InVivoMAb anti-mouse Thy1 (CD90)
| 5 mg
| BioXCell
| in vitro T cell depletion
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0009-5MG
| InVivoMAb anti-mouse CD18
| 5 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0047-25MG
| InVivoMAb anti-mouse IL-6R
| 25 mg
| BioXCell
| in vivo blocking of IL-6/IL-6R signaling, in vitro
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0000-5MG
| InVivoMAb anti-mouse CD1d (CD1.1)
| 5 mg
| BioXCell
| in vivo CD1d neutralization, in vitro CD1d neutral
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0015-5-1MG
| InVivoMAb anti-mouse CD28
| 1 mg
| BioXCell
| in vitro T cell stimulation/activation
|
| Armenian Hamster
| Mouse
| Request Quotation
| Request
|
| BE0051-1MG
| InVivoMAb anti-mouse IL-12 p40
| 1 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Request Quotation
| Request
|
| BE0050-5MG
| InVivoMAb anti-mouse IL-10R (CD210)
| 5 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Request Quotation
| Request
|